In: European Journal of Innovation Management, 2003, vol. 6, no. 1, p. 48-63
Many new products are based on new technologies, which may in turn be based on new scientific discoveries. The extant literature on new product development has focused on how a firm may successfully commercialize new products. There is a corporate cost associated with new product failure, which extends beyond the final product-manufacturing corporation to all the parties involved in the...
|
In: Interactive CardioVascular and Thoracic Surgery, 2016, vol. 22, no. 4, p. 402-405
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 26, no. 4, p. 545-550
|
In: Interactive CardioVascular and Thoracic Surgery, 2016, vol. 22, no. 5, p. 647-662
|
In: Journal of Business Ethics, 2015, vol. 126, no. 2, p. 309-323
|
In: Blood, 2020, vol. 137, no. 10, p. 1365–1376
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B cell receptor immunoglobulins (BcR IG). Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR IG stereotypy in CLL has important implications for understanding disease...
|
In: Journal of Anesthesia, 2014, vol. 28, no. 4, p. 580-586
|
In: Surgical Endoscopy, 2014, vol. 28, no. 5, p. 1613-1623
|
In: Journal of Business Ethics, 2006, vol. 66, no. 1, p. 71-88
|
In: Journal of Nuclear Cardiology, 2010, vol. 17, no. 1, p. 4-7
|